Figure 1
From: Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
Pro-coagulation clotting pathway proteins that were increased in women with polycystic ovary syndrome (PCOS). Levels of plasma plasminogen activator inhibitor 1 (A), fibrinogen (B), fibrinogen gamma chain (C), fibronectin (D), von Willebrand factor (E), D-dimer (F), P-selectin (G) and plasma kallikrein (H) in women with and without polycystic ovary syndrome (PCOS). RFU, relative fluorescent units. Graphs shown as mean ± SEM. ^p < 0.05, *p < 0.01, **p < 0.001, ***p < 0.0001.
